Cite
HARVARD Citation
Youngblood, M. et al. (2023). Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. Neuro-oncology. 25 (3), pp. 508-519. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Youngblood, M. et al. (2023). Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. Neuro-oncology. 25 (3), pp. 508-519. [Online].